GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
David Begnaud meets a man who has attended the Kentucky Derby for 79 years in a row – and his dying wish to make it there one last time....
The trio of high school students — Brody Murray, 17, Logan Royer, and Cody Magrone, both 16 — were dining at a McDonald's on April 19 when they noticed Diego Fernandez-Delgado changing his tire and de...
Ukrainian drones struck residential buildings in Russia’s Ryazan, killing three people and injuring 12 others, according to the governor...
